Drug intelligence / Profile preview

Anxinbao

Development stage
Phase 4
Lead developer
Guangdong Women and Children Hospital
Modality
Small Molecules
Administration
Oral
01

Overview

Anxinbao (also known as Anxinbao Mixture) is a proprietary Chinese herbal hospital preparation developed by the Reproductive Medicine Center of Guangdong Maternal and Child Health Hospital. It is specifically formulated to treat female infertility associated with thin endometrium and recurrent implantation failure (RIF). The preparation is based on Traditional Chinese Medicine (TCM) principles of tonifying the kidney and activating blood circulation to improve the uterine environment. Clinically, it is used to increase endometrial thickness and improve endometrial receptivity, thereby enhancing the success rates of embryo transfer in assisted reproductive technology (ART) cycles. Research indicates that its mechanism may involve the up-regulation of key markers such as Homeobox protein HOXA10 and Vascular endothelial growth factor (VEGF), which are critical for embryo implantation and angiogenesis.

Brand names
Anxinbao
Other names
Anxinbao MixtureAnxinbao Heji安欣宝安欣宝合剂
02

Targets

HOXA10 (Homeobox protein Hox-A10)VEGFA (Vascular endothelial growth factor A)

Beyond the preview

Go deeper on Anxinbao.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Anxinbao.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call